Sanara Medtech Inc
NASDAQ:SMTI
Balance Sheet
Balance Sheet Decomposition
Sanara Medtech Inc
Current Assets | 19m |
Cash & Short-Term Investments | 5.1m |
Receivables | 8.5m |
Other Current Assets | 5.3m |
Non-Current Assets | 54.9m |
Long-Term Investments | 3.1m |
PP&E | 3.3m |
Intangibles | 48.5m |
Current Liabilities | 13.8m |
Accounts Payable | 2m |
Accrued Liabilities | 10.1m |
Other Current Liabilities | 1.7m |
Non-Current Liabilities | 15.3m |
Long-Term Debt | 9.1m |
Other Non-Current Liabilities | 6.2m |
Balance Sheet
Sanara Medtech Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
1
|
0
|
1
|
0
|
1
|
7
|
0
|
19
|
9
|
5
|
|
Cash |
1
|
0
|
1
|
0
|
1
|
7
|
0
|
19
|
9
|
5
|
|
Total Receivables |
0
|
0
|
1
|
1
|
0
|
1
|
2
|
3
|
7
|
9
|
|
Accounts Receivables |
0
|
0
|
1
|
1
|
0
|
1
|
2
|
3
|
7
|
9
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
4
|
5
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
Total Current Assets |
1
|
1
|
2
|
2
|
1
|
9
|
4
|
25
|
21
|
19
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
32
|
45
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
2
|
0
|
1
|
5
|
3
|
3
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
|
Total Assets |
2
N/A
|
1
-7%
|
2
+56%
|
2
+2%
|
3
+37%
|
11
+266%
|
10
-12%
|
36
+270%
|
61
+68%
|
74
+21%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
|
Accrued Liabilities |
1
|
1
|
1
|
1
|
0
|
2
|
3
|
5
|
10
|
10
|
|
Short-Term Debt |
2
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Total Current Liabilities |
2
|
1
|
1
|
2
|
0
|
3
|
4
|
6
|
13
|
14
|
|
Long-Term Debt |
0
|
1
|
1
|
0
|
2
|
2
|
0
|
0
|
0
|
9
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
7
|
6
|
|
Total Liabilities |
2
N/A
|
3
+15%
|
3
-3%
|
2
-18%
|
2
-9%
|
5
+133%
|
4
-18%
|
6
+57%
|
19
+234%
|
29
+51%
|
|
Equity | |||||||||||
Common Stock |
1
|
1
|
1
|
1
|
0
|
11
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
45
|
47
|
47
|
47
|
47
|
3
|
7
|
15
|
23
|
28
|
|
Additional Paid In Capital |
44
|
45
|
46
|
46
|
48
|
2
|
13
|
46
|
65
|
73
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
1
N/A
|
1
-53%
|
0
+67%
|
0
N/A
|
1
+1 010%
|
7
+495%
|
6
-7%
|
31
+398%
|
42
+37%
|
45
+7%
|
|
Total Liabilities & Equity |
2
N/A
|
1
-7%
|
2
+56%
|
2
+2%
|
3
+37%
|
11
+266%
|
10
-12%
|
36
+270%
|
61
+68%
|
74
+21%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
1
|
1
|
1
|
1
|
2
|
4
|
6
|
8
|
8
|
9
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|